VITAL CAPACITY DECREASED

This adverse event was reported 448 times

These drugs are most commonly taken by patients reporting VITAL CAPACITY DECREASED:

# Drug Count
0 PREDNISONE 205
1 MONTELUKAST SODIUM 200
2 ALBUTEROL SULFATE 187
3 MEPOLIZUMAB 184
4 OMALIZUMAB 157
5 BISOPROLOL FUMARATE 125
6 FUROSEMIDE 125
7 ACETAMINOPHEN 116
8 LEVOTHYROXINE SODIUM 109
9 TIOTROPIUM BROMIDE 107
See all common drugs associated with VITAL CAPACITY DECREASED

VITAL CAPACITY DECREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DEXTROSE AND SODIUM CHLORIDE 1 0.0060
1 TROLAMINE SALICYLATE 1 0.0052
2 ACLIDINIUM BROMIDE 24 0.0038
3 MEPOLIZUMAB 184 0.0036
4 THEOPHYLLINE ANHYDROUS 45 0.0036
5 ROSUVASTATIN CALCIUM 96 0.0033
6 CHLOROQUINE PHOSPHATE 2 0.0030
7 RABEPRAZOLE SODIUM 75 0.0027
8 CICLESONIDE 37 0.0027
9 GLYCOPYRROLATE 14 0.0025
See all drugs enriched for association with VITAL CAPACITY DECREASED

VITAL CAPACITY DECREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 184 0.2674
1 Anti-IgE [EPC] 157 0.0018
2 Leukotriene Receptor Antagonist [EPC] 35 0.0012
3 Methylxanthine [EPC] 46 0.0008
4 Aldosterone Antagonist [EPC] 92 0.0006
5 Benzothiazole [EPC] 1 0.0004
6 Expectorant [EPC] 70 0.0003
7 Provitamin D2 Compound [EPC] 9 0.0003
8 Loop Diuretic [EPC] 129 0.0003
9 Neonatal Fc Receptor Blocker [EPC] 1 0.0002
See all drug classes enriched for association with VITAL CAPACITY DECREASED